| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Diabetic Neuropathies | D003929 | 5 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Dilatation, Pathologic | D004108 | 5 associated lipids |
| Disease Susceptibility | D004198 | 12 associated lipids |
| Emphysema | D004646 | 1 associated lipids |
| Encephalitis | D004660 | 15 associated lipids |
| Endocrine System Diseases | D004700 | 4 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Eye Neoplasms | D005134 | 2 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Koufany M et al. | The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway. | 2013 | Arthritis Rheum. | pmid:23982996 |
| Naumnik B et al. | Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients. | 2013 | Adv Med Sci | pmid:23959668 |
| Chen X et al. | Environmental level of cadmium exposure stimulates osteoclasts formation in male rats. | 2013 | Food Chem. Toxicol. | pmid:23954550 |
| pmid:23943168 | ||||
| Pichler K et al. | Towards a better understanding of bone bridge formation in the growth plate - an immunohistochemical approach. | 2013 | Connect. Tissue Res. | pmid:23941205 |
| Horshuns'ka MIu et al. | [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. | 2013 May-Jun | Ukr Biokhim Zh (1999) | pmid:23937044 |
| Zhang J et al. | Feeding blueberry diets to young rats dose-dependently inhibits bone resorption through suppression of RANKL in stromal cells. | 2013 | PLoS ONE | pmid:23936431 |
| Crosley LK et al. | The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. | 2013 | Mol Nutr Food Res | pmid:23934705 |
| pmid:23934086 | ||||
| Kim SD et al. | Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. | 2013 | Biochem. Pharmacol. | pmid:23928189 |
| Steensma MR et al. | Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy. | 2013 | PLoS ONE | pmid:23922683 |
| Kim HR et al. | The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients. | 2013 | Nephron Clin Pract | pmid:23921088 |
| Nile CJ et al. | Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease. | 2013 | J. Clin. Periodontol. | pmid:23919740 |
| Bauer S et al. | Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study. | 2013 | Epilepsy Res. | pmid:23916144 |
| Albu A et al. | Bone metabolism regulators and arterial stiffness in postmenopausal women. | 2013 | Maturitas | pmid:23916080 |
| Pacifici R | Osteoimmunology and its implications for transplantation. | 2013 | Am. J. Transplant. | pmid:23915249 |
| Naranjo-Suarez S et al. | Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status. | 2013 | Mol. Cells | pmid:23912593 |
| Enhos S et al. | OPG and RANKL levels around miniscrew implants during orthodontic tooth movement. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23910201 |
| Lekesiz K et al. | Effect of unfractionated heparin, enoxaparin and sulodexide on the relations between secretion and expression of OPG, RANKL and vWF in HUVEC. | 2013 | Folia Histochem. Cytobiol. | pmid:23907946 |
| Thormann U et al. | Bone formation induced by strontium modified calcium phosphate cement in critical-size metaphyseal fracture defects in ovariectomized rats. | 2013 | Biomaterials | pmid:23906515 |
| Szymczak J and Bohdanowicz-Pawlak A | Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate. | 2013 | Horm. Metab. Res. | pmid:23888411 |
| Canalis E et al. | Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling. | 2013 | J. Biol. Chem. | pmid:23884415 |
| Esteghamati A et al. | Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. | 2013 Jul-Aug | J. Endocrinol. Invest. | pmid:23877020 |
| Zhou S et al. | Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway. | 2013 | PLoS ONE | pmid:23874840 |
| Salbach-Hirsch J et al. | The promotion of osteoclastogenesis by sulfated hyaluronan through interference with osteoprotegerin and receptor activator of NF-κB ligand/osteoprotegerin complex formation. | 2013 | Biomaterials | pmid:23871544 |
| Dahl JS et al. | Relation of osteoprotegerin in severe aortic valve stenosis to postoperative outcome and left ventricular function. | 2013 | Am. J. Cardiol. | pmid:23871267 |
| Cao H et al. | Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery. | 2013 | Ann. Thorac. Surg. | pmid:23870696 |
| Wei CC et al. | Total glucosides of paeony prevents juxta-articular bone loss in experimental arthritis. | 2013 | BMC Complement Altern Med | pmid:23870279 |
| pmid:23869744 | ||||
| Steagall WK et al. | Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. | 2013 | Am. J. Pathol. | pmid:23867796 |
| Zhou J et al. | [Effect of sinusoidal electromagnetic fields on rats femur tissue cultivation in vitro]. | 2013 | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | pmid:23865319 |
| Mogi M and Kondo A | The presence of RANKL-OPG complex in human osteosarcoma U2OS. | 2013 | J Immunoassay Immunochem | pmid:23859786 |
| Wang Q et al. | The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women. | 2013 | Int. Immunopharmacol. | pmid:23856613 |
| Riesco M et al. | Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures. | 2013 | Clin. Rheumatol. | pmid:23846386 |
| Zhang PF et al. | Interrelationship of circulating matrix metalloproteinase-9, TNF-α, and OPG/RANK/RANKL systems in COPD patients with osteoporosis. | 2013 | COPD | pmid:23845033 |
| Xiong Q et al. | [Effects of recombinant human osteoprotegerin and recombinant RANK protein on the differentiation of osteoclast precursors]. | 2013 | Zhongguo Gu Shang | pmid:23844495 |
| de Araújo Júnior RF et al. | Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis. | 2013 | PLoS ONE | pmid:23843954 |
| Puato M et al. | Impact of hypertension on vascular remodeling in patients with psoriatic arthritis. | 2014 | J Hum Hypertens | pmid:23842084 |
| Zhu J et al. | The influence of g.19124G>a genetic polymorphism in the OPG gene on bone mineral density in Chinese women. | 2013 | Genet Test Mol Biomarkers | pmid:23837846 |
| Xu F et al. | Adipocytes regulate the bone marrow microenvironment in a mouse model of obesity. | 2013 | Mol Med Rep | pmid:23835909 |
| Baud'huin M et al. | Osteoprotegerin: multiple partners for multiple functions. | 2013 | Cytokine Growth Factor Rev. | pmid:23827649 |
| pmid:23826645 | ||||
| Fu YX et al. | Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions. | 2013 | J. Vet. Sci. | pmid:23820214 |
| Meneghini M et al. | Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation. | 2013 | Transplantation | pmid:23812001 |
| pmid:23805811 | ||||
| Gordin D et al. | Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. | 2013 | Diabetes Care | pmid:23801795 |
| Welldon KJ et al. | Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. | 2013 | Mol. Cell. Endocrinol. | pmid:23791847 |
| Anastasilakis AD et al. | Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. | 2013 | J. Clin. Endocrinol. Metab. | pmid:23788684 |
| Ghaffari S et al. | The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography. | 2013 | Cardiol J | pmid:23788300 |
| Liu M et al. | Semen Astragali Complanati- and Rhizoma Cibotii-enhanced bone formation in osteoporosis rats. | 2013 | BMC Complement Altern Med | pmid:23782721 |
| Zhang Y et al. | Expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on osteoclasts and its potential role in rheumatoid arthritis. | 2013 | Clinics (Sao Paulo) | pmid:23778340 |
| Løgstrup BB et al. | Microvascular dysfunction is associated with plasma osteoprotegerin levels in patients with acute myocardial infarction. | 2013 | Coron. Artery Dis. | pmid:23777975 |
| pmid:23775573 | ||||
| Araújo AA et al. | Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. | 2013 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:23775504 |
| Neunaber C et al. | Differentiation of osteoprogenitor cells is affected by trauma-haemorrhage. | 2013 | Injury | pmid:23773407 |
| Jiang XY et al. | TNFRSF11B polymorphisms are associated with metabolic traits in Uyghur and Han ethnic groups. | 2014 | Endocr. Res. | pmid:23772656 |
| Weiss RM et al. | Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. | 2013 | PLoS ONE | pmid:23762316 |
| Lee HJ et al. | Association between polymorphisms in leptin, leptin receptor, and β-adrenergic receptor genes and bone mineral density in postmenopausal Korean women. | 2014 | Menopause | pmid:23760429 |
| Pateinakis P et al. | Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients. | 2013 | BMC Nephrol | pmid:23758931 |
| Antonoglou G et al. | Serum osteoprotegerin and periodontal destruction in subjects with type 1 diabetes mellitus. | 2013 | J. Clin. Periodontol. | pmid:23758409 |
| Takeuchi S et al. | Acidosis inhibits mineralization in human osteoblasts. | 2013 | Calcif. Tissue Int. | pmid:23754489 |
| Ostrowska Z et al. | Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. | 2013 | Postepy Hig Med Dosw (Online) | pmid:23752595 |
| Xi L et al. | OPG/RANK/RANKL axis in atrial fibrillation. | 2013 | Cardiology | pmid:23752030 |
| Tao H et al. | OPG/RANK/RANKL axis as a potential therapeutic target for atrial fibrillation. | 2013 | Cardiology | pmid:23751957 |
| Janda K et al. | [The relationship between advancement of secondary hyperparathyroidism and selected calcification parameters in peritoneal dialysis patients]. | 2012 | Prz. Lek. | pmid:23750431 |
| Danks L and Takayanagi H | Immunology and bone. | 2013 | J. Biochem. | pmid:23750028 |
| Rahnama M et al. | Influence of hormone replacement therapy on osteoprotegerin and receptor activator of nuclear factor kappa-B ligand concentrations in menopausal women. | 2013 | J. Interferon Cytokine Res. | pmid:23745763 |
| Shen Q et al. | Curculigoside promotes osteogenic differentiation of bone marrow stromal cells from ovariectomized rats. | 2013 | J. Pharm. Pharmacol. | pmid:23738728 |
| LaCroix AZ et al. | OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational Study. | 2013 | Bone | pmid:23735608 |
| Wu X et al. | Screening of osteoprotegerin-related feature genes in osteoporosis and functional analysis with DNA microarray. | 2013 | Eur. J. Med. Res. | pmid:23731710 |
| Recht M et al. | The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption. | 2013 | Haemophilia | pmid:23731369 |
| Wan S | Editorial comment: The end of all our exploring ... | 2013 | Eur J Cardiothorac Surg | pmid:23729753 |
| Saini V et al. | Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. | 2013 | J. Biol. Chem. | pmid:23729679 |
| Kim J et al. | Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis. | 2013 | Clin. Biochem. | pmid:23726804 |
| Brzóska MM and Rogalska J | Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats. | 2013 | Toxicol. Appl. Pharmacol. | pmid:23726800 |
| Marshall AJ et al. | Long-chain triazolyl acids as inhibitors of osteoclastogenesis. | 2013 | Bioorg. Med. Chem. | pmid:23726411 |
| Sagar DR et al. | Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. | 2014 | Ann. Rheum. Dis. | pmid:23723320 |
| Hakimi M et al. | The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients. | 2013 | Int. J. Mol. Med. | pmid:23722820 |
| Ding Q and Zhang FQ | [Effect of icariin on the expression of receptor activator nuclear factor-κB ligand and osteoprotegerin of human periodontal ligament cells]. | 2013 | Zhonghua Kou Qiang Yi Xue Za Zhi | pmid:23714056 |
| pmid:23710898 | ||||
| Luo J et al. | 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. | 2013 | Biomed Res Int | pmid:23710436 |
| Uehara H et al. | Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin. | 2013 | Int. J. Oncol. | pmid:23708710 |
| Mercatali L et al. | RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study. | 2013 | Int J Mol Sci | pmid:23702841 |
| pmid:23701481 | ||||
| Suliburska J et al. | The association of insulin resistance with serum osteoprotegerin in obese adolescents. | 2013 | J. Physiol. Biochem. | pmid:23695991 |
| Lou Z et al. | Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone. | 2013 | Med. Oncol. | pmid:23690270 |
| Rody WJ et al. | Differences in the gingival crevicular fluid composition between adults and adolescents undergoing orthodontic treatment. | 2014 | Angle Orthod | pmid:23687969 |
| Fu YX et al. | Influence of osteoprotegerin on differentiation, activation, and apoptosis of Gaoyou duck embryo osteoclasts in vitro. | 2013 | Poult. Sci. | pmid:23687158 |
| Jiang S et al. | Changes of blood parameters associated with bone remodeling following experimentally induced fatty liver disorder in laying hens. | 2013 | Poult. Sci. | pmid:23687138 |
| Olivares-Navarrete R et al. | Rough titanium alloys regulate osteoblast production of angiogenic factors. | 2013 | Spine J | pmid:23684238 |
| Kato R et al. | Gap-junction-mediated communication in human periodontal ligament cells. | 2013 | J. Dent. Res. | pmid:23677649 |
| Jun AY et al. | Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts. | 2014 | Invest New Drugs | pmid:23673814 |
| Galeone A et al. | Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. | 2013 | Eur J Cardiothorac Surg | pmid:23671202 |
| Marano RJ et al. | Prolactin expression in the cochlea of aged BALB/c mice is gender biased and correlates to loss of bone mineral density and hearing loss. | 2013 | PLoS ONE | pmid:23667691 |
| Kim JY et al. | Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress. | 2013 | Arthritis Rheum. | pmid:23666878 |
| Ding CZ et al. | [Effects of zhengqing fengtongning tablet and methotrexate on the serum OPG/RANKL and IL-17 of collagen-induced arthritis rats]. | 2013 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:23646485 |
| Xie GQ et al. | Relationship between serum TGF-β1, OPG levels and osteoporotic risk in native Chinese women. | 2013 | Clin. Chim. Acta | pmid:23643930 |
| Kaludjerovic J and Ward WE | Adequate but not supplemental folic acid combined with soy isoflavones during early life improves bone health at adulthood in male mice. | 2013 | J. Nutr. Biochem. | pmid:23643520 |
| Chandran V et al. | Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis. | 2013 | J. Rheumatol. | pmid:23637322 |
| Bradaschia-Correa V et al. | Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats. | 2013 | Cell Tissue Res. | pmid:23636419 |